In addition, during the fourth quarter, Tang Capital initiated a stake in OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), of which it owns 365,000 shares. The fund also closed its stakes in four other companies.
Read more at http://www.insidermonkey.com/blog/heron-therapeutics-inc-hrtx-la-jolla-pharmaceutical-company-ljpc-salix-pharmaceuticals-ltd-slxp-are-tang-capitals-largest-bets-in-q4-338658/2/#v9J4v80rGwWeGFDe.99
Dan Rosenblum @sharkbiotech 1m1 minute ago
$ICPT gets breakthough designation for OCA in NASH
which insider? Are you saying that all insiders dumped? It wouldn't surprise me at all
EGLT got OXECTA for free pretty much. They will recoup their investment in less than one quarter and pay out on royalties. Great for them sucks for ACUR. They company only has their technology to sell now. They certainly are not going to be able to keep running on royalty payments.
It's a mee too drug that has a lot of competition. Also, the terms of the deal are less than stellar so with those two overhangs I do not believe you will see ACUR share price improve from where it is. The only thing left at this point would be to sell the company and I do not believe there is a lot of interest.
In accordance with NASDAQ Listing Rule 5810(c)(3)(A), the Company has been provided a period of 180 calendar days, or until March 17, 2015
Doc I fully agree except the hail mary part. I honestly cant say I know one biotech that threw a Hail Mary and pulled it off. If there is one that you know of please let me know. It would give me some hope like the hope these others carry with them. I can never figure out where they get it from.
first of all I am sure you mean 1 for 10. second, all they need to do is get it above 1.00 so they could do a 1 for 2. Chances are they want some room to dilute or whatever else kind of financing so my guess is 1 for 4. More likely 1 for 5. I am all ears if you think they have another option...please enlighten us.
Yeah Doc I hate to be right too but it is reality. These guys won't spend a penny to buy their own stock and at the rate things are going we are headed to a reverse and more dilution. This partnership that everyone was waiting for is a BIG disappointment. They all but paid Eglet to take the drug. There is nothing left in their bag of tricks. Certainly not Nexafed.
Institutional holders will not go to pink sheets. They Have to hear a plan from the BOD of ACUR. So while the individual investors sit on their hands and wait for news, the plan for a reverse split to maintain Nasdaq requirements or to let the stock go to pink sheets is in motion or already done. I am betting that there will be a reverse split. If I am right there will be a new round of financing that will dilute our shares while maintaining the value to the institutional investors who finance the next round. Tic toc
these guys need to really upgrade their valuation model. As usual they are a year late and many dollars short.
Thanks Colima. People are tele commuting/mass transit more when they can see how much they can save a month/year. Even though gas prices have fallen they are now comfortable taking the train/bus or whatever. I don't think they will go back to sitting in traffic even for lower gas prices. At least this is how it is on the West Coast. JMO
Sentiment: Strong Buy
yeah I guess I better sit back and keep some popcorn and beer at the ready...could be more fireworks...looks like a compelling buy at these levels though
Sentiment: Strong Buy
yeah, you are right. The other posters that keep hope alive because of the perfume and lipstick they put on this pig. Freedom is a wonderful thing and once they bail they will know freedom. It hurts for a bit and then you realize that you salvaged something to start anew. However small it may be.
that the "event" is over, the directors and officers are allowed to buy...or sell. Let's see which they do. My guess is sell and if that happens get out.